Filing metadata

Accession number
0001140361-21-013158
Form type
Form 3
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Apr 16, 2021
Reporting period
Mar 25, 2021
Description
Initial ownership

Explore SEC Filings Hub